Cléo presented first results from our analysis of volatile organic compounds in individuals with type 1 diabetes during induced hypoglycemia using a breath analyzer at the ATTD conference in Florence.
Cléo presented first results from our analysis of volatile organic compounds in individuals with type 1 diabetes during induced hypoglycemia using a breath analyzer at the ATTD conference in Florence.